Gene silencing of HIF-2α disrupts glioblastoma stem cell phenotype

Abstract

Aim: Improved treatment strategies are desperately needed for eradicating cancer stem cells (CSCs), which drive malignancy and recurrence in glioblastoma multiforme. Hypoxic regions within the tumor microenvironment help maintain and promote the proliferation of CSCs. Here, we explored the effects of silencing hypoxia inducible factor-2α (HIF-2α) because of its specificity for CSCs within the hypoxic environment.

Methods: Cancer stem cell neurospheres were formed by enriching from both the glioblastoma cell line U87 and from brain tumor stem cells isolated directly from human brain tumors. Silencing of human HIF-2α was performed using both commercial and in-house transfection of a validated short interfering RNA, with all results compared to an established non-silencing control short interfering RNA. Silencing of HIF-2α was established by Western blotting, and phenotypic effects were assayed by cell migration assays, cell viability measurements, and immunofluorescence staining of differentiation markers.

Results: Transfection with either our previously reported pH-sensitive, cationic amphiphilic macromolecule-based delivery system or Lipofectamine was similarly effective in silencing HIF-2α. The chemotherapeutic resistance and neurosphere formation were reduced when HIF-2α was silenced. Migratory capacities in the presence of macrophage conditioned media were modulated. HIF-2α silencing was complementary to temozolomide treatment in producing phenotypic rather than cytotoxic effects.

Conclusion: HIF-2α silencing under hypoxia inhibited CSC phenotypes while promoting differentiated cell phenotypes and is complementary to existing DNA alkylating treatments in inhibiting glioma CSC activity.

Keywords

Glioblastoma multiforme / cancer stem cell / short interfering RNA / tumor hypoxia

References

[1] Heddleston JM,Rivera M,Lathia JD.Hypoxia-induced mixed-lineage leukemia 1 regulates glioma stem cell tumorigenic potential..Cell Death Differ2012;19:428-39 PMCID:PMC3229666

[2] Garvalov BK.Cancer stem cells: a new framework for the design of tumor therapies..J Mol Med (Berl)2011;89:95-107

[3] Jain RK.Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia..Cancer Cell2014;26:605-22 PMCID:PMC4269830

[4] Mpekris F,Stylianopoulos T.Role of vascular normalization in benefit from metronomic chemotherapy..Proc Natl Acad Sci U S A2017;114:1994-9 PMCID:PMC5338413

[5] Kaelin WG Jr.The VHL tumor suppressor gene: insights into oxygen sensing and cancer..Trans Am Clin Climatol Assoc2017;128:298-307 PMCID:PMC5525432

[6] Colwell N,Giles AJ,Sizdahkhani S.Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells..Neuro Oncol2017;19:887-96 PMCID:PMC5570138

[7] Renfrow JJ,Debinski W,Mott RT.Hypoxia-inducible factor 2alpha: a novel target in gliomas..Future Med Chem2018;10:2227-36 PMCID:PMC6479274

[8] Pietras A,Pahlman S.The HIF-2alpha-driven pseudo-hypoxic phenotype in tumor aggressiveness, differentiation, and vascularization..Curr Top Microbiol Immunol2010;345:1-20

[9] Kolenda J,Aaberg-Jessen C,Andersen C.Effects of hypoxia on expression of a panel of stem cell and chemoresistance markers in glioblastoma-derived spheroids..J Neurooncol2011;103:43-58

[10] Lofstedt T,Holmquist-Mengelbier L,Ovenberger M.Hypoxia inducible factor-2alpha in cancer..Cell Cycle2007;6:919-26

[11] Koh MY.Passing the baton: the HIF switch..Trends Biochem Sci2012;37:364-72 PMCID:PMC3433036

[12] Wu A,Kong LY,Priebe W.Glioma cancer stem cells induce immunosuppressive macrophages/microglia..Neuro Oncol2010;12:1113-25 PMCID:PMC3098021

[13] Eubank TD,Liu H,Marsh CB.Opposing roles for HIF-1alpha and HIF-2alpha in the regulation of angiogenesis by mononuclear phagocytes..Blood2011;117:323-32 PMCID:PMC3037754

[14] Leek RD.Tumor-associated macrophages in breast cancer..J Mammary Gland Biol Neoplasia2002;7:177-89

[15] Wang Q,Huang M,Wang Y.Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2alpha..Nat Commun2018;9:559 PMCID:PMC5805734

[16] Johannessen TC.Molecular mechanisms of temozolomide resistance in glioblastoma multiforme..Expert Rev Anticancer Ther2012;12:635-42

[17] Gedye C.Isolation and characterization of cancer stem cells in vitro..Methods Mol Biol2013;946:181-204

[18] Nusblat LM,Roth CM.Crosstalk between M2 macrophages and glioma stem cells..Cell Oncol (Dordr)2017;40:471-82

[19] Yu SC,Yi L,Chen JH.Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87..Cancer Lett2008;265:124-34

[20] Visnyei K,Damoiseaux R,Petrosyan S.A molecular screening approach to identify and characterize inhibitors of glioblastoma stem cells..Mol Cancer Ther2011;10:1818-28 PMCID:PMC3191241

[21] Elstner A,von Deimling A.Involvement of Hif-1 in desferrioxamine-induced invasion of glioblastoma cells..Clin Exp Metastasis2007;24:57-66

[22] Lu H,Shu M,Huang Y.Hypoxia-inducible factor-1alpha blocks differentiation of malignant gliomas..FEBS J2009;276:7291-304

[23] Gu L,Tishbi N,Pinson CM.Cationic amphiphilic macromolecule (CAM)-lipid complexes for efficient siRNA gene silencing..J Control Release2014;184:28-35 PMCID:PMC4090228

[24] Beier D,Beier CP.Chemoresistance of glioblastoma cancer stem cells--much more complex than expected..Mol Cancer2011;10:128 PMCID:PMC3207925

[25] Qiu ZK,Chen YS,Guo CC.Enhanced MGMT expression contributes to temozolomide resistance in glioma stem-like cells..Chin J Cancer2014;33:115-22 PMCID:PMC3935013

[26] Li Z,Eyler CE,Rich JN.Turning cancer stem cells inside out: an exploration of glioma stem cell signaling pathways..J Biol Chem2009;284:16705-9 PMCID:PMC2719304

[27] Sparks SM,Harmon AM,Roth CM.Efficient intracellular siRNA delivery by ethyleneimine-modified amphiphilic macromolecules..Macromol Biosci2011;11:1192-200 PMCID:PMC3549469

[28] Sun X,Liu D,Zhang N.Novel biomimetic vectors with endosomal-escape agent enhancing gene transfection efficiency..Int J Pharm2012;425:62-72

[29] Viswanath P,Izquierdo-Garcia JL,Gregory Cairncross J.Mutant IDH1 gliomas downregulate phosphocholine and phosphoethanolamine synthesis in a 2-hydroxyglutarate-dependent manner..Cancer Metab2018;6:3 PMCID:PMC5881177

[30] Méndez O,Esencay M,Santovasi D.Knock down of HIF-1alpha in glioma cells reduces migration in vitro and invasion in vivo and impairs their ability to form tumor spheres..Mol Cancer2010;9:133 PMCID:PMC2896954

[31] Bache M,Kessler J,Wichmann H.mRNA expression levels of hypoxia-induced and stem cell-associated genes in human glioblastoma..Oncol Rep2015;33:3155-61

[32] Lee G,Guo D,Deheeger M.Dedifferentiation of glioma cells to glioma stem-like cells by therapeutic stress-induced HIF signaling in the recurrent GBM model..Mol Cancer Ther2016;15:3064-76 PMCID:PMC5298928

[33] Luwor R,Amiridis S,Paradiso L.Targeting glioma stem cells by functional inhibition of dynamin 2: a novel treatment strategy for glioblastoma..Cancer Invest2019;37:144-55

[34] Sun T,Galstyan A,Ding H.Blockade of a laminin-411-notch axis with CRISPR/Cas9 or a nanobioconjugate inhibits glioblastoma growth through tumor-microenvironment cross-talk..Cancer Res2019;79:1239-51 PMCID:PMC6625517